1,816
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Determination and confirmation of selective estrogen receptor modulators (SERMs), anti-estrogens and aromatase inhibitors in bovine and porcine urine using UHPLC-MS/MS

, , , &
Pages 641-651 | Received 14 Sep 2016, Accepted 16 Dec 2016, Published online: 31 Jan 2017

References

  • De la Torre X, Colamonici C, Curcio D, Jardines D, Molaioni F, Parr MK, Botrè F. 2014. Detection of formestane abuse by mass spectrometric techniques. Drug Test Anal. 6:1133–1140.
  • De Rijke E, Essers ML, Rijk JCW, Thevis M, Bovee TFH, van Ginkel LA, Sterk SS. 2013. Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis. Food Addit Contam Part A. 30:1517–1526.
  • Dutertre M, Smith CL. 2000. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther. 295:431–437. Epub 2000 Oct 25.
  • EFSA Panel on Contaminants in the Food Chain. 2013. Guidance on methodological principles and scientific methods to be taken into account when establishing Reference Points for Action (RPAs) for non-allowed pharmacologically active substances present in food of animal origin. EFSA J. 11:3195.
  • [EC] European Commission. 2002. Commission decision 2002/657/EC implementing council directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Commun L. 221:8–36.
  • Gerace E, Salomone A, Abbadessa G, Racca S, Vincenti M. 2012. Rapid determination of anti-estrogens by gas chromatography/mass spectrometry in urine: method validation and application to real samples. J Pharm Anal. 2:1–11.
  • Ho EN, Leung DK, Leung GN, Wan TS, Wong HN, Xu X, Yeung JH. 2007. Metabolic studies of mesterolone in horses. Anal Chim Acta. 596:149–155. Epub 2007 Jul 10.
  • Kang M-J, Hwang YH, Lee W, Kim D-H. 2007. Validation and application of a screening method for β2-agonists, anti-estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 21:252–264.
  • Krug O, Thomas A, Walpurgis K, Piper T, Sigmund G, Schanzer W, Laussmann T, Thevis M. 2014. Identification of black market products and potential doping agents in Germany 2010-2013. Eur J Clin Pharmacol. 70:1303–1311.
  • Leung GNW, Kwok WH, Wan TSM, Lam KKH, Schiff PJ. 2013. Metabolic studies of formestane in horses. Drug Test Anal. 5:412–419.
  • Lønning PE. 2004. Aromatase inhibitors in breast cancer. Endocr Relat Cancer. 11:179–189.
  • Mareck U, Sigmund G, Opfermann G, Geyer H, Thevis M, Schänzer W. 2005. Identification of the aromatase inhibitor letrozole in urine by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 19:3689–3693.
  • Mauras N, O’Brien KO, Klein KO, Hayes V. 2000. Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metabolism. 85:2370–2377.
  • Mazzarino M, Botrè F. 2006. A fast liquid chromatographic/mass spectrometric screening method for the simultaneous detection of synthetic glucocorticoids, some stimulants, anti-oestrogen drugs and synthetic anabolic steroids. Rapid Commun Mass Spectrom. 20:3465–3476.
  • Mazzarino M, Braganò MC, de la Torre X, Molaioni F, Botrè F. 2011. Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses. Steroids. 76:1400–1406.
  • Piper T, Fusshöller G, Emery C, Schänzer W, Saugy M. 2012. Investigations on carbon isotope ratios and concentrations of urinary formestane. Drug Test Anal. 4:942–950.
  • Poelmans S, De Wasch K, De Brabander HF, Van De Wiele M, Courtheyn D, van Ginkel LA, Sterk SS, Delahaut P, Dubois M, Schilt R, et al. 2002. Analytical possibilities for the detection of stanozolol and its metabolites. Anal Chim Acta. 473:39–47.
  • Polet M, Van Renterghem P, Van Gansbeke W, Van Eenoo P. 2013. Profiling of urinary formestane and confirmation by isotope ratio mass spectrometry. Steroids. 78:1103–1109.
  • Regal P, Nebot C, Vázquez BI, Cepeda A, Fente CA. 2010. Determination of the hormonal growth promoter 17α-methyltestosterone in food-producing animals: bovine hair analysis by HPLC–MS/MS. Meat Sci. 84:196–201.
  • RIKILT Wageningen University & Research. 2013. SOP 1160 – bovine and porcine urine, meat fish and liver. The analysis of a large number of hormones. Wageningen: GC-MS/MS.
  • Sterk SS, van Tricht EF, Stephany RW. 1998. Lyophilised samples of blank urine for the validation and quality control of residue analysis for growth promoting compounds. Bilthoven: RIVM. Monograph Wageningen UR Library C1 -NN31014, 1998-45.
  • World Anti Doping Agency. 2015. WADA technical document – TD21015MRPL – minimum required performance levels for detection and identification of non-threshold substances. Montreal: World Anti Doping Agency.
  • World Anti Doping Agency. 2016. WADA technical document – TD2016IRMS. Detection of synthetic forms of endogenous anabolic androgenic steroids by GC/C/IRMS. Montreal: World Anti Doping Agency.